Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05146362 · ClinicalTrials.gov registry record · NA
Vermont RETAIN Impact Evaluation
A NA study, sponsored by Mathematica Policy Research.
- Completed
- Registry status
- NA
- Development phase
- 798
- Enrollment target
NCT05146362: Completed NA study, sponsored by Mathematica Policy Research.
NCT05146362 is a NA study that has completed, run by Mathematica Policy Research. The registered enrollment target is 798 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05146362, a NA study, has completed, sponsored by Mathematica Policy Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 798 participants
- Enrollment target
Study Summary
The Retaining Employment and Talent after Injury/Illness Network (RETAIN) demonstration is a collaborative effort between the U.S. Department of Labor (DOL) and the Social Security Administration (SSA) to improve employment outcomes for individuals who experience injuries or illnesses that put them at risk of exiting the labor force and relying on disability programs and other public supports in the long term. RETAIN projects include a combination of medical provider services, stay-at-work/return-to-work (SAW/RTW) coordination services, and other SAW/RTW services. This evaluation will focus on the Vermont Department of Labor's implementation of "Vermont RETAIN" statewide. The evaluation will document how the project is implemented, describe enrollees, estimate the project's impacts on enrollees' outcomes, and assess whether the benefits outweigh the costs.
Primary Outcome
Share of enrollees employed in the fourth quarter after enrollment obtained from state unemployment insurance wage records. These files include individual-level wage records for six quarters surrounding enrollment in the study, including the quarter prior to enrollment, the quarter of enrollment, and four post-enrollment quarters.
Interventions
- OTHER Vermont RETAIN
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 798 participants |
| Start Date | 2022-02-01 |
| Est. Completion | 2026-02-28 |
| Phase | NA |
What the finished NCT05146362 record still lists
NCT05146362 is an interventional study that assigns participants to a tested intervention. The registered 798 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% lower).
The record links to 0 conditions, and to 1 intervention - of which Vermont RETAIN is the first listed.
NCT05146362 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05146362 about?
NCT05146362 is a clinical study titled "Vermont RETAIN Impact Evaluation". The Retaining Employment and Talent after Injury/Illness Network (RETAIN) demonstration is a collaborative effort between the U.S. Department of Labor (DOL) and the Social Security Administration (SSA) to improve employment outcomes for individuals who experience injuries or illnesses that put them ...
What is the current status of trial NCT05146362?
This trial is currently completed. It is a NA study. The enrollment target is 798 participants. The study started on 2022-02-01. Estimated completion is 2026-02-28.
What interventions are being tested in trial NCT05146362?
The interventions under investigation include: Vermont RETAIN (OTHER).
Who is sponsoring clinical trial NCT05146362?
This trial is sponsored by Mathematica Policy Research, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05146362's enrollment target sits among peer trials
798 140th of 2000 higher than 1,861 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06051058 · 798 participants · NA
Care Transitions App for Patients With Multiple Chronic Conditions
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI